Dexcel Pharma Technologies Ltd.

Insider Reports History

Location: 1 Dexcel Street, Or Akiva, Israel
Signature: /s/ Dexcel Pharma Technologies Ltd. by Dan Oren, Executive Chairman
All insider transactions: Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Dexcel Pharma Technologies Ltd.:

Stock	Role	Class	Num Shares	Value	Price $	Report Date	Ownership
Roivant Sciences Ltd.	10%+ Owner	Common Shares	103M	$1.06B	$10.35	Nov 10, 2022	Direct
Protalix BioTherapeutics, Inc.	10%+ Owner	Common Stock	3.64M	$5.13M	$1.41	Jun 3, 2021	Direct

Showing 1 to 2 of 2 entries

Insider Reports Filed by Dexcel Pharma Technologies Ltd.

Symbol	Company	Period	Transactions	Value $	Form Type	Date Filed	Role
ROIV	Roivant Sciences Ltd.	Nov 10, 2022	1	$20M	4	Nov 14, 2022	10%+ Owner
ROIV	Roivant Sciences Ltd.	Apr 22, 2022	2	$155K	4	Apr 26, 2022	10%+ Owner
ROIV	Roivant Sciences Ltd.	Oct 1, 2021	0	$0	3	Oct 1, 2021	10%+ Owner
PLX	Protalix BioTherapeutics, Inc.	Jun 2, 2021	2	-$2.09M	4	Jun 3, 2021	10%+ Owner